转移因子胶襄联合单磷酸阿糖腺苷治疗带状疱疹疗效观察

发布时间：2018-03-19 04:37

本文选题：带状疱疹　切入点：转移因子胶囊　出处：《海峡药学》2016年11期 　论文类型：期刊论文

【摘要】：目的探究转移因子胶囊联合单磷酸阿糖腺苷治疗带状疱疹的临床疗效。方法将于2013年3月至2015年5月在我皮肤病门诊接受治疗的带状疱疹患者50例作为研究对象,并随机分为对照组和实验组各25例。对照组患者单独服用转移因子胶囊进行治疗,实验组患者在对照组的基础上再采用静脉滴注单磷酸阿糖腺苷进行治疗。记录治疗后两组患者的止疱时间、止痛时间、结痂时间以及脱痂时间;计算两组患者治疗后临床总体有效率。结果治疗后,对照组患者的总体有效率为72%,实验组患者的总体有效率为和92%,两组差异有统计学意义(P0.05);对照组患者止疱时间、止痛时间、结痂时间、脱痂时间均高于实验组,实验组与对照组相比具有显著性差异(P0.05)。结论转移因子胶囊联合静脉滴注单磷酸阿糖腺苷对带状疱疹患者具有疗程短、起效快、能有效缓解疼痛、总体有效率高的特点,具有较强的临床效果,值得临床推广。
[Abstract]:Objective to investigate the clinical efficacy of transfer factor capsule combined with adenosine arabinomonophosphate in the treatment of herpes zoster. Methods 50 cases of herpes zoster treated in our dermatologic clinic from March 2013 to May 2015 were studied. The patients in the control group were treated with transfer factor capsule alone. The patients in the experimental group were treated by intravenous infusion of adenosine arabinoside monophosphate on the basis of the control group. Results after treatment, the total effective rate of the patients in the control group was 72 and that of the patients in the experimental group was 92. The difference between the two groups was statistically significant (P 0.05). The time of scab formation and eschar removal in the experimental group was higher than that in the experimental group, and there was a significant difference between the experimental group and the control group. Conclusion transfer factor capsule combined with intravenous infusion of adenosine monophosphate has a short course of treatment and a quick effect on patients with herpes zoster. It can relieve pain effectively, has high overall efficiency, has strong clinical effect, and is worth popularizing.
【作者单位】：福建省南平市疾病预防控制中心皮肤科;
【分类号】：R752.12

【相似文献】